Benicar and Hypercalcaemia aggravated - a phase IV clinical study of FDA data

Summary:

Hypercalcaemia aggravated is reported as a side effect among people who take Benicar (olmesartan medoxomil), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Lasix, and have Osteoporosis.

The phase IV clinical study analyzes which people have Hypercalcaemia aggravated when taking Benicar. It is created by eHealthMe based on reports of 34,073 people who have side effects when taking Benicar from the FDA, and is updated regularly.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.

What is Hypercalcaemia aggravated?

Hypercalcaemia aggravated (elevated calcium (ca+) level in the blood. (norma) is found to be associated with 932 drugs and 344 conditions by eHealthMe. Check the latest studies of Hypercalcaemia aggravated.

On Aug, 10, 2026

34,073 people reported to have side effects when taking Benicar.
Among them, 17 people (0.05%) have Hypercalcaemia aggravated.

Could Benicar cause Hypercalcaemia aggravated?

Among these 17 people:

How long have people been on Benicar when they have Hypercalcaemia aggravated? *

What is the gender of people who have Hypercalcaemia aggravated when taking Benicar? *

female: 80 %
male: 20 %

What is the age of people who have Hypercalcaemia aggravated when taking Benicar? *

What are other drugs people take besides Benicar? *

Norvasc: 6 people, 35.29%
Lasix: 6 people, 35.29%
Fosamax: 5 people, 29.41%
Novolog: 5 people, 29.41%
Estrace: 5 people, 29.41%
Lopressor: 4 people, 23.53%
Penicillin G Potassium: 4 people, 23.53%
Morphine: 4 people, 23.53%
Metoclopramide: 4 people, 23.53%
Decadron: 4 people, 23.53%

What are other side effects people have besides Hypercalcaemia aggravated? *

Stress And Anxiety: 11 people, 64.71%
Fall: 10 people, 58.82%
Oedema Peripheral (superficial swelling): 9 people, 52.94%
Dyslipidaemia (abnormal amount of lipids): 9 people, 52.94%
Femur Fracture: 9 people, 52.94%
Chest Pain: 9 people, 52.94%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 7 people, 41.18%
Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 41.18%
Weakness: 7 people, 41.18%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 6 people, 35.29%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 8 people, 47.06%
Osteopenia (a condition where bone mineral density is lower than normal): 5 people, 29.41%
Menopause (end of monthly cycles in women): 5 people, 29.41%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 23.53%
Multiple Myeloma (cancer of the plasma cells): 4 people, 23.53%
Renal Disorder (kidney disease): 1 person, 5.88%
Prostate Cancer Metastatic: 1 person, 5.88%
Pathological Fracture (broken bone caused by disease): 1 person, 5.88%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Benicar and have Hypercalcaemia aggravated?

- Check whether Hypercalcaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benicar:

Benicar (36,002 reports)

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercalcaemia aggravated:

Hypercalcaemia aggravated (932 drugs)

Browse all the conditions that are associated with Hypercalcaemia aggravated:

Hypercalcaemia aggravated (344 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil (the active ingredients of Benicar) and Benicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.